Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung CancerJie Lei, Tao Jiang, Li Gong et al.|JAMA Oncology|2023Cited by 96
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axisXiyang Tang, Jinbo Zhao|Frontiers in Immunology|2022Cited by 54
<p>Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer</p>Zhao Huang, Jinbo Zhao|OncoTargets and Therapy|2019Cited by 12